Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Weight loss company Noom is offering an at-home biomarker testing kit for its U.S. members, expanding its platform into diagnostics and metabolic health monitoring. | Weight loss company Noom is offering an at-home biomarker testing kit for its U.S. members, expanding its platform into diagnostics and metabolic health monitoring.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise

For wearables, it’s a GLP-1 world

Signos grows foothold in weight-loss wave fueled by GLP-1s with its AI health data tracking

Signos raises $20M, expands Dexcom partnership for weight loss

Acute Patients Embrace At-Home Monitoring, Emphasizing Device Comfort and Ease of Use as Driving Adoption

Signos raises $20M as it eyes health plan, pharma relationships

Accelerating Targeted Gene Expression Analysis in Drug Development

Discover the best ways to save on Noom subscriptions, including free trials, limited-time offers for GLP-1Rx Plus, and essential…

NEW YORK (Reuters) -Online weight-loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's…

Within 24 hours of injecting the first dose of a weight loss medication she received following a visit with a telehealth doctor,…

Eugene, Ore.-based Ksana Health is undertaking a multi | The software company is partnering with several health systems,…

Whoop Advanced Labs marries subscription blood tests with its fitness device monitoring for tech-powered wellness advice.

The announcement expands the offerings under the company's weight management program as its membership grows to more than 800,000.